We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$17.6M
Cap. Flow
-$128M
Cap. Flow %
-4.73%
Top 10 Hldgs %
84.41%
Holding
222
New
44
Increased
27
Reduced
52
Closed
66
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY icon
126
Occidental Petroleum
OXY
$53.5B
$782K 0.03%
25,000
-5,000
-17% -$134K
AGI icon
127
Alamos Gold
AGI
$13.1B
$764K 0.03%
100,000
COIN icon
128
Coinbase
COIN
$39.5B
$760K 0.03%
+3,000
New +$779K
SPOK icon
129
Spok Holdings
SPOK
$235M
$722K 0.03%
75,000
TSLA icon
130
Tesla
TSLA
$1.27T
$680K 0.03%
+3,000
New +$651K
BB icon
131
BlackBerry
BB
$5.12B
$672K 0.02%
55,000
-40,000
-42% -$419K
AXTI icon
132
AXT Inc
AXTI
$4.49B
$659K 0.02%
60,000
ATEC icon
133
Alphatec Holdings
ATEC
$1.47B
$643K 0.02%
42,000
-18,000
-30% -$278K
DCOY
134
Decoy Therapeutics
DCOY
$2.23M
$621K 0.02%
16
-27
-63% -$1.2M
CSV icon
135
Carriage Services
CSV
$657M
$596K 0.02%
16,120
-10,280
-39% -$384K
PASG icon
136
Passage Bio
PASG
$14.8M
$530K 0.02%
2,000
-1,750
-47% -$541K
TAL icon
137
TAL Education Group
TAL
$6.71B
$482K 0.02%
19,100
GEL icon
138
Genesis Energy
GEL
$1.82B
$464K 0.02%
40,000
-50,000
-56% -$505K
FLL icon
139
Full House Resorts
FLL
$80.5M
$446K 0.02%
44,832
-180,168
-80% -$1.74M
XPEV icon
140
XPeng
XPEV
$11.2B
$444K 0.02%
+10,000
New +$341K
DCRC
141
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$415K 0.02%
+40,000
New +$417K
TCRR
142
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$394K 0.01%
24,000
NBSE
143
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$389K 0.01%
+4,060
New +$448K
SNCR
144
DELISTED
Synchronoss Technologies
SNCR
$359K 0.01%
+11,111
New +$312K
PLL
145
DELISTED
Piedmont Lithium
PLL
$313K 0.01%
+4,000
New +$271K
VYGR icon
146
Voyager Therapeutics
VYGR
$187M
$268K 0.01%
+65,000
New +$295K
RYM
147
RYTHM Inc
RYM
$54.5M
$238K 0.01%
7
-6
-46% -$188K
GBNH
148
DELISTED
Greenbrook TMS Inc. Common Shares
GBNH
$212K 0.01%
+17,520
New +$202K
BMTX.WS
149
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$182K 0.01%
71,000
EUCRW
150
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$138K 0.01%
133,332

Similar funds

Granite Point Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Granite Point Capital Management held 222 positions worth $2.7B, up 0.66% from $2.68B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Granite Point Capital Management withdrew a net $128M in Q2 2021, closing 66 positions and reducing 52 holdings. Its most notable exit was Quotient Technology Inc, an estimated $8.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.9% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Granite Point Capital Management opened a new position in Angel Pond Holdings Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant worth $12M.

  • Granite Point Capital Management's largest Q2 2021 buy was Angel Pond Holdings Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant: 1,200,000 shares worth $12M.
  • Granite Point Capital Management added most to New Oriental in Q2 2021, an estimated $5.1M increase.
  • Granite Point Capital Management's biggest Q2 2021 reduction was Neuronetics, cutting an estimated $6.26M.
  • Granite Point Capital Management fully exited Quotient Technology Inc in Q2 2021, selling an estimated $8.18M.
  • Granite Point Capital Management's ten largest holdings make up 84% of its $2.7B portfolio in Q2 2021.
  • Granite Point Capital Management opened 44 new positions and closed 66 in Q2 2021.
  • Granite Point Capital Management's portfolio value rose 0.66% quarter-over-quarter to $2.7B.

Based on Granite Point Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.